$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?
02:59pm, Monday, 05'th May 2025
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) will report its first-quarter earnings on Monday. As the company reports after market hours, Wall Street expects $4.32 in EPS and $2.85 billion in revenues.
Final Trades: Berkshire Hathaway, Vertex Pharma, S&P Global and CME Group
01:38pm, Wednesday, 30'th Apr 2025
Final Trades are in! The Investment Committee reveals their top picks to close out the day—don't miss it!
Vertex (VERX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:05am, Wednesday, 30'th Apr 2025
Vertex (VERX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vertex Announces Strategic Investment in AI Tax Compliance Startup Kintsugi
08:00am, Wednesday, 30'th Apr 2025
KING OF PRUSSIA, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, today announced it has
Will Vertex (VERX) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Tuesday, 29'th Apr 2025
Vertex (VERX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?
08:55am, Tuesday, 29'th Apr 2025
On VRTX's first-quarter earnings call, investors are likely to focus on the launch preparation for Alyftrek (vanza triple) and Journavx (suzetrigine).
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
05:37pm, Tuesday, 22'nd Apr 2025
Vertex Pharmaceuticals (VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% higher in price, on the back of two positive mentions by analysts tracking t
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely
01:58pm, Monday, 21'st Apr 2025
Vertex Pharmaceuticals Inc VRTX is entering earnings week with some serious anticipation — and a bit of heartburn. The stock had a solid run in 2025, up nearly 20% year-to-date and 21% over the past
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner Internati
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
03:45am, Friday, 11'th Apr 2025
Vertex Pharmaceuticals (VRTX -1.39%) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is even ex
Final Trades: Vertex, Robinhood, Palo Alto and Crowdstrike
01:28pm, Thursday, 10'th Apr 2025
The Investment Committee give you their top stocks to watch in this volatile markets.
Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives
08:00am, Thursday, 10'th Apr 2025
Leading industry experts join the Vertex Chief Strategy Office to shape product innovation and strengthen global compliance strategies for customers Leading industry experts join the Vertex Chief Stra
Elasticsearch Now Available as a Native Grounding Engine on Google Cloud's Vertex AI Platform
09:00am, Wednesday, 09'th Apr 2025
SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC), the Search AI Company, announced that the Elasticsearch vector database is now a natively supported information retrieval engine for Google Cloud'
Is Vertex Pharmaceuticals Stock a Buy?
09:45am, Tuesday, 08'th Apr 2025
Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (VRTX 0.75%). Compared to the S&P 500 index, which is down about 16% f
Sign In
Buy VERX